Sanderling Venture Partners VI Co Investment Fund LP 4
4 · FAVRILLE INC · Filed Feb 17, 2005
Insider Transaction Report
Form 4
FAVRILLE INCFVRL
SANDERLING V LTD PARTNERSHIP
10% Owner
Transactions
- Conversion
Common Stock
2005-02-07+2,020,521→ 2,039,795 total - Purchase
Common Stock
2005-02-07$7.00/sh+1,142,857$7,999,999→ 3,182,652 total - Conversion
Series B Convertible Preferred Stock
2005-02-07−790,042→ 0 total→ Common Stock (790,042 underlying) - Conversion
Series B-2 Convertible Preferred Stock
2005-02-07−319,756→ 0 total→ Common Stock (319,756 underlying) - Conversion
Series C Convertible Preferred Stock
2005-02-07−838,132→ 0 total→ Common Stock (910,723 underlying)
Footnotes (9)
- [F1]The shares are held as follows: 209,587 shares by Sanderling V Limited Partnership ("SV LP"), 186,491 shares by Sanderling V Beteiligungs, GmbH & Co. KG ("Beteiligungs"), 980,216 shares by Sanderling Venture Partners V, L.P. ("SVPV"), 240,099 shares by Sanderling V Biomedical, L.P. ("Biomedical"), 37,414 shares by Sanderling V Ventures Management ("SVVM"), 687,657 shares by Sanderling Venture Partners V Co-Investment Fund, L.P. ("Venture Co-Investment"), 416,902 shares by Sanderling V Biomedical Co-Investment Fund, L.P. ("Biomedical Co-Investment") and 424,286 shares by Sanderling Venture Partners VI Co-Investment Fund, L.P. ("Ventures VI"). Middleton, McNeil & Mills Associates V, LLC ("MMM") is the general partner of SVLP, Beteiligungs, SVPV, Biomedical, Venture Co-Investment, Biomedical Co-Investment and Ventures VI.
- [F2]1-for-1
- [F3]Immediate
- [F4]Not applicable.
- [F5]Price does not apply.
- [F6]The shares are held as follows: 54,119 shares by SV LP, 48,155 shares by Beteiligungs, 546,102 shares by SVPV, 133,766 shares by Biomedical and 7,900 shares by SVVM.
- [F7]1.086614-for-1
- [F8]The shares are held as follows: 21,904 shares by SVLP, 19,490 shares by Beteiligungs, 221,026 shares by SVPV, 54,139 shares by Biomedical and 3,197 shares by SVVM.
- [F9]The shares are held as follows: 68,604 shares by SV LP, 61,044 shares by Beteiligungs, 96,557 shares by SVPV, 23,651 shares by Biomedical, 8,381 shares by SVVM, 361,021 shares by Venture Co-Investment, and 218,874 shares by Biomedical Co-Investment.